12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

A/H5N1 Avian Influenza Vaccine: Phase I data

Top-line data from a pair of single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials in a total of 666 healthy volunteers aged 18-49 showed that 2 intramuscular injections of Novavax's A/H5N1 Avian Influenza Vaccine given 21 days apart with or...

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >